Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab ... - PR Newswire (press release)

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab ... PR Newswire (press release), NY Improvements in the Assessment in Ankylosing Spondylitis criteria (ASAS 20) were maintained through two years in each of the study arms: "In the GO-RAISE trial, treatment with golimumab provided sustained symptom relief to patients living with the ... Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab ... FOXBusiness all 25 news articles